Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price

(AJANTPHARM)

₹2663.74.47%

as on 04:01PM, 20 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Ltd Performance

  • Day's Low

    Day's High

    ₹2,602.85
    Day's Price Range
    ₹2,768.95
  • 52 Week's Low

    52 Week's High

    ₹1,998.35
    52-Week Price Range
    ₹3,485
1 Month Return-3.2 %
3 Month Return-5.33 %
1 Year Return+ 31.81 %
Previous Close₹2,788.40
Open₹2,750.00
Volume4.24L
Upper Circuit-
Lower Circuit-
Market Cap₹34,830.49Cr

Ajanta Pharma Ltd Key Statistics

P/E Ratio

38.99

PEG Ratio

2.94

Market Cap

₹34,830.49 Cr

P/B Ratio

8.28

EPS

64.6

Dividend Yield

2.29

Sector

Pharmaceuticals

ROE

24.24

Ajanta Pharma Ltd Analyst Rating

based on 10 analysts

BUY

60.00%

Buy

10.00%

Hold

30.00%

Sell

Based on 10 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹3029.9

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share analysis

Ajanta Pharma Ltd price forecast by 10 analysts

Upside of8.66%

High

₹3667

Target

₹3029.90

Low

₹2288

Ajanta Pharma Ltd target price ₹3029.9, a slight upside of 8.66% compared to current price of ₹2663.7. According to 10 analysts rating.

Source: S&P Global Market Intelligence

Key events for Ajanta Pharma Ltd

  • Ajanta Pharma Rises for Fifth Consecutive Session - 03 Feb, 2025

    Ajanta Pharma Ltd surged 2.5% today, marking its fifth consecutive session of gains. The stock is up 28.7% over the past year, despite a recent 5.45% decline in the last month. The Nifty Pharma index has also seen a drop of 8.32% in the same period.
  • Ajanta Pharma Reports Strong Q3 Results and Target Price - 31 Jan, 2025

    Ajanta Pharma's Q3 results show an 11% profit increase to ₹233 crore and a 4% revenue rise. Motilal Oswal sets a target price of ₹3,220, reflecting positive analyst sentiment.
  • Ajanta Pharma Reports Strong Q3 Profit Growth - 30 Jan, 2025

    Ajanta Pharma announced an 11% increase in consolidated profit after tax for Q3 2024, reaching Rs 233 crore, up from Rs 210 crore last year. Revenue also rose to Rs 1,146 crore. Following the results, shares closed 1.64% higher at Rs 2,670.70 on BSE.
  • Brokerage Issues Buy Call for Ajanta Pharma - 08 Jan, 2025

    A brokerage has issued a buy recommendation for Ajanta Pharma Ltd, setting a target price of Rs 3360, indicating a potential upside of 13.30%. A stop loss is advised at Rs 2752.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 216.48 Cr → 232.88 Cr (in ₹), with an average increase of 7.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AJANTPHARM stock has moved up by 11.7%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.11% to 9.26% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 17.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 28.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 14.93% to 14.89% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.52% to 7.45% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.20K Cr → 1.17K Cr (in ₹), with an average decrease of 2.5% per quarter

Ajanta Pharma Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,105.15Cr (-)₹1,054.08Cr (↓4.62%)₹1,144.92Cr (↑8.62%)₹1,186.64Cr (↑3.64%)₹1,146.13Cr (↓3.41%)
Net Income₹210.03Cr (-)₹202.72Cr (↓3.48%)₹245.77Cr (↑21.24%)₹216.48Cr (↓11.92%)₹232.88Cr (↑7.58%)
Net Profit Margin19.00% (-)19.23% (↑1.21%)21.47% (↑11.65%)18.24% (↓15.04%)20.32% (↑11.40%)
Value in ₹ crore
Details2021202220232024
Total Assets₹3,532.06Cr (-)₹3,808.64Cr (↑7.83%)₹4,339.09Cr (↑13.93%)₹4,252.44Cr (↓2.00%)
Total Liabilities₹647.08Cr (-)₹639.46Cr (↓1.18%)₹1,092.64Cr (↑70.87%)₹838.87Cr (↓23.23%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹300.88Cr (-)₹466.99Cr (↑55.21%)₹542.34Cr (↑16.14%)₹736.29Cr (↑35.76%)₹735.35Cr (↓0.13%)

Index Inclusions

NIFTY PHARMA

₹20,785.75

-0.16 (-34.25%)

BSE Healthcare

₹40,263.69

0.4 (159.55%)

Nifty LargeMidcap 250

₹14,528.15

0.73 (104.75%)

S&P BSE 150 MidCap

₹14,175.42

1.24 (173.19%)

BSE Mid-Cap

₹40,854.88

1.18 (478.2%)

S&P BSE 400 MidSmallCap

₹10,582.55

1.23 (128.5%)

BSE 500

₹32,757.57

0.46 (149.8%)

Nifty MidSmallcap 400

₹17,400.70

1.28 (219.75%)

S&P BSE 250 LargeMidCap

₹9,778.61

0.38 (37.32%)

Nifty Midcap 150

₹18,888.80

1.31 (243.9%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Nifty 500

₹20,831.10

0.48 (99.65%)

Ajanta Pharma Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66.26%
0.00
Foreign Institutions
9.26%
1.59
Mutual Funds
14.89%
-0.28
Retail Investors
7.45%
-0.87
Others
2.14%
-1.74

Ajanta Pharma Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)35.5550.1355.3446.5464.6
Details20202021202220232024
Return On Equity %19.1725.2823.7817.4224.24
Details20202021202220232024
Return On Assets %15.3418.5118.7113.5519.19
Details20202021202220232024
Book Value Per Share (₹)197.56229.68253.5268.14282.34

Ajanta Pharma Ltd Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (38.99x)

February 19, 2025

Industry (51.87x)

February 19, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Ajanta Pharma Ltd Earnings and Dividends

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 10.88% since last year same period to ₹232.88Cr in the Q3 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated 7.58% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28 - translating a dividend yield of 2.03%.

    Read More about Dividends

Ajanta Pharma Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ajanta Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.

Ajanta Pharma Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹34,830.49 Cr37.87%0.51₹816 Cr₹4,208 Cr
BUY₹12,048.61 Cr-5.69%0.52₹602 Cr₹2,851 Cr
BUY₹66,515.75 Cr17.86%0.56₹3,168 Cr₹29,001 Cr
HOLD₹89,700.73 Cr43.85%0.64₹3,854 Cr₹19,547 Cr
BUY₹63,157.44 Cr18.28%0.53NANA

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Share Price: ₹2663.70 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹34,830.49Cr as of today
Revenue: ₹1,146.13Cr as on December 2024 (Q4 24)
Net Profit: ₹232.88Cr as on December 2024 (Q4 24)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Ajanta Pharma Ltd

What is Ajanta Pharma Ltd price today?

Ajanta Pharma Ltd share price today stands at ₹2663.7, Open: ₹2750, Previous Close: ₹2788.4, High: ₹2768.95, Low: ₹2602.85, 52 Week High: ₹3485, 52 Week Low: ₹1998.35.

How to Buy Ajanta Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Ajanta Pharma Ltd shares

Is Ajanta Pharma Ltd listed on NSE?

Ajanta Pharma Ltd is listed on NSE

Is Ajanta Pharma Ltd listed on BSE?

Ajanta Pharma Ltd is listed on BSE

What are today's High and Low prices of Ajanta Pharma Ltd?

  • Today's highest price of Ajanta Pharma Ltd is ₹2768.95.
  • Today's lowest price of Ajanta Pharma Ltd is ₹2602.85.

What are today's traded volumes of Ajanta Pharma Ltd?

Today's traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 4.24L.

What is today's market capitalisation of Ajanta Pharma Ltd?

Today's market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹34830.49Cr.

What is the 52 Week High and Low Range of Ajanta Pharma Ltd?

Ajanta Pharma Ltd (AJANTPHARM)
Price
52 Week High
₹3485
52 Week Low
₹1998.35

How much percentage Ajanta Pharma Ltd is down from its 52 Week High?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2663.7. It is down -23.57% from its 52 Week High price of ₹3485

How much percentage Ajanta Pharma Ltd is up from its 52 Week low?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2663.7. It is up 33.29% from its 52 Week Low price of ₹1998.35

What are the historical returns of Ajanta Pharma Ltd?

Ajanta Pharma Ltd (AJANTPHARM)
Returns
1 Day Returns
-124.7%
1 Month Returns
-3.2%
3 Month Returns
-5.33%
1 Year Returns
31.81%

What is the PE ratio of Ajanta Pharma Ltd today?

PE Ratio of Ajanta Pharma Ltd is 38.99

PE ratio = Ajanta Pharma Ltd Market price per share / Ajanta Pharma Ltd Earnings per share